Objective: To describe the indications for total abdominal hysterectomy for women with nonmalignant disease and to determine the immediate (initial ten days) and medium term outcome.
Design: A prospective cohort study.
Setting: Three district general hospitals in shire counties, two in outer London and one London teaching hospital.
Subjects: Three hundred and sixty-six women undergoing total abdominal hysterectomy (with or without other procedures) for nonmalignant disease.
Interventions: Self-completed patient questionnaires before and ten days, six weeks and three months after surgery. Data extracted from patients' hospital case notes.
Main Outcome Measures: Complications plus change in symptoms, urinary and bowel function, general health status, sexual function, activities of daily living and quality of life.
Results: The principal indications were bleeding, pain or both. Symptoms were severe enough to be socially debilitating and have a major impact on lifestyle. Otherwise, the women were in good health. During the first ten post-operative days the women suffered more pain, urinary discomfort, constipation and a reduction in their ability to perform activities of daily living. Urinary (25%) and wound (25%) infections were the commonest complications. At the same time, significant improvements in psychological health occurred. By six weeks, the principal symptoms had resolved for 95% of the women and early adverse effects on urinary and bowel function had settled. This was reflected in improvements in health status and quality of life including sexual activity. Despite this, these changes did not meet the pre-operative expectations of some women.
Conclusions: Most women reported substantial benefits from hysterectomy. However, women should be warned about early, transient adverse effects. These findings can serve as a benchmark for nonexperimental evaluations of the effectiveness of new treatment modalities.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1471-0528.1995.tb11398.x | DOI Listing |
Pediatr Radiol
January 2025
Izaak Walton Killam Health Centre, Halifax, Nova Scotia, B3K 6R8, Canada.
Background: Image-defined risk factors (IDRFs) were introduced to provide a consensus approach for pre-treatment risk stratification on computed tomography (CT) and magnetic resonance imaging (MRI) in patients with neuroblastoma.
Objective: To assess the intra- and inter-reader agreement of radiologists in identifying IDRFs on CT.
Materials And Methods: Approval for this retrospective study was granted by our institutional research ethics board with a waiver of consent.
Anaesthesia
January 2025
Department of Anaesthesia and Perioperative Medicine, The Royal Brisbane and Women's Hospital, Brisbane, Australia.
Introduction: Evidence to support intra-operative lidocaine infusion regimens in patients with obesity is lacking, risking underdosing or toxicity. We aimed to measure the plasma concentrations of lidocaine and its active metabolites to develop a pharmacokinetic model and optimised dosing regimen in patients with obesity.
Methods: A standardised weight-based intravenous lidocaine regimen was administered to patients with a BMI ≥ 30 kg.
Front Med (Lausanne)
December 2024
Department of Cardiology, The Third Hospital of Mianyang/Sichuan Mental Health Center, Mianyang, Sichuan, China.
Aim: We aimed to systematically assess whether the level of body roundness index (BRI) is associated with the risk of developing chronic kidney disease (CKD) in US adults.
Methods: The studied data was extracted from the National Health and Nutrition Examination Survey (NHANES) spanning from 1999 to 2018. A total of 29,062 participants aged ≥20 years with complete information about BRI and CKD were included in this study.
World J Hepatol
December 2024
Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, Peking University Ditan Teaching Hospital, Beijing 100015, China.
Background: The incidence of () infection in patients with cirrhosis has been increasing over recent years, posing certain difficulties in clinical treatment.
Aim: To analyze the clinical features of patients with liver cirrhosis and identify the risk factors to help the early diagnosis and treatment of these diseases.
Methods: Clinical data and laboratory tests were collected from 72 patients with cirrhosis confirmed by secretion or blood culture of infection at Beijing Ditan Hospital, Capital Medical University, between May 2016 and October 2018.
Pathol Res Pract
December 2024
Division of Clinical Genome Research, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!